Relapse as indicated by admission to acute care (inpatient wards, crisis resolution teams, crisis houses and acute day services) during the 12-month follow-up period. Data on admissions to acute care during the trial period is collected from patient records at the 12-month follow-up. Key Secondary Outcomes 1. Social outcomes are measured using The Social Outcomes Index (Priebe, Watzke, Hansson & Burns, 2008) at the study baseline meeting, at a 4-month follow-up meeting and at a 12-month follow-up meeting 2. Mental wellbeing is assessed using The Mental Health Confidence Scale (Carpinello et al., 2000) and The WarwickEdinburgh Mental Well-Being Scale (NHS Health Scotland, University of Warwick & University of Edinburgh, 2007) at the study baseline meeting, at a 4-month follow-up meeting and at a 12-month follow-up meeting 3. Recovery in psychosis is assessed using The Process of Recovery Questionnaire (Neil et al., 2009 ) at the study baseline meeting, at a 4-month follow-up meeting and at a 12-month follow-up meeting 4. Quality of life and satisfaction with treatment is assessed using The DIALOG scale (Priebe et al., 2007) at the study baseline meeting, at a 4-month follow-up meeting and at a 12-month follow-up meeting 5. Positive, negative and general psychopathology symptoms are assessed using the PANSS (Kat et al., 1987) 
